Slim Weight Loss Clinic

Slim Weight Loss Clinic operates as a telehealth-focused weight management practice serving patients throughout Nevada from its Las Vegas base. Under the medical direction of Dr. Gary T. Marshall, MD, FACS, a board-certified surgeon with fellowship training, the clinic specializes in pharmacological interventions for obesity and metabolic health optimization. The practice has earned a 4.8-star rating across 360 Google reviews, reflecting consistent patient outcomes in medically supervised weight reduction programs. Dr. Marshall's surgical background informs his approach to weight loss as a medical condition requiring evidence-based pharmaceutical intervention rather than willpower alone.

The clinic's treatment protocol centers on three glucagon-like peptide-1 (GLP-1) receptor agonists: liraglutide, semaglutide, and tirzepatide. Liraglutide is typically prescribed as a daily subcutaneous injection for patients requiring gradual appetite regulation and glycemic control. Semaglutide, administered weekly, offers enhanced weight reduction potential through prolonged GLP-1 receptor activation and delayed gastric emptying. Tirzepatide represents the clinic's dual-action option, combining GLP-1 and glucose-dependent insulinotropic polypeptide (GIP) receptor agonism for patients who have plateaued on single-mechanism therapies. Dr. Marshall individualizes peptide selection based on patient metabolic profiles, comorbid conditions such as type 2 diabetes, and prior treatment response, rather than following a one-size-fits-all prescribing pattern.

Dr. Marshall's credentials as a Fellow of the American College of Surgeons (FACS) distinguish his clinical perspective on obesity treatment. His surgical training provides insight into the physiological mechanisms of weight regulation and the metabolic consequences of excess adiposity, including insulin resistance, hepatic steatosis, and cardiovascular strain. This background enables him to identify patients who may benefit from pharmacotherapy versus those requiring more intensive interventions. The clinic's medical protocols include baseline metabolic panels, thyroid function assessment, and cardiovascular risk stratification before initiating GLP-1 therapy. Patients receive detailed education on injection technique, dose escalation schedules to minimize gastrointestinal side effects, and recognition of contraindications such as personal or family history of medullary thyroid carcinoma.

The telehealth delivery model allows Nevada residents to access specialized obesity medicine without geographic barriers. Initial consultations involve comprehensive review of weight history, previous diet attempts, medication lists, and metabolic laboratory work. Dr. Marshall conducts video assessments to evaluate patient suitability for peptide therapy and to screen for conditions that may complicate treatment, such as gastroparesis or severe renal impairment. Follow-up visits occur monthly during dose titration phases, then quarterly once therapeutic dosing is achieved. The clinic coordinates prescription fulfillment through partner pharmacies and provides ongoing monitoring of weight trends, side effect profiles, and metabolic markers including hemoglobin A1c and lipid panels. Patients receive structured guidance on protein intake targets to preserve lean muscle mass during caloric deficit, hydration protocols, and physical activity progression appropriate to their current fitness level.

Slim Weight Loss Clinic differentiates itself through Dr. Marshall's surgical expertise applied to medical weight management, offering a physician-led alternative to nurse practitioner-only telehealth platforms. The Las Vegas clinic maintains a focused scope limited to evidence-based pharmacological obesity treatment rather than attempting to provide comprehensive primary care. This specialization allows for refined protocols, extensive experience with GLP-1 peptide titration strategies, and systematic approaches to managing common adverse effects such as nausea, constipation, and injection site reactions. The clinic's 360-review patient base reflects sustained engagement rather than transactional prescribing, with established systems for prior authorization navigation, insurance verification for obesity medications, and transparent self-pay pricing for patients whose plans exclude weight management drugs. Nevada patients seeking medically supervised peptide therapy for obesity have access to board-certified physician oversight through a telehealth platform designed specifically for longitudinal metabolic disease management.